KK
CYTK icon

KLP Kapitalforvaltning’s Cytokinetics CYTK Stock Holding History

KLP Kapitalforvaltning’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Hold
25,600
– – 0.01% 732
2026
Q1 		$1.69M Buy
25,600
+1,300
+5% +$82.6K 0.01% 779
2025
Q4 		$1.54M Buy
24,300
+300
+1% +$18.7K 0.01% 812
2025
Q3 		$1.32M Hold
24,000
– – 0.01% 880
2025
Q2 		$793K Buy
24,000
+400
+2% +$13.9K ﹤0.01% 1111
2025
Q1 		$948K Buy
23,600
+600
+3% +$27.6K ﹤0.01% 964
2024
Q4 		$1.08M Buy
+23,000
New +$1.19M 0.01% 954

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's CYTK Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Cytokinetics (CYTK) position steady in Q2 2026 at 25,600 shares worth $2.18M. The position accounts for 0.01% of the portfolio, ranked #732.

KLP Kapitalforvaltning first reported a position in CYTK in Q4 2024 and has held it in 7 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • KLP Kapitalforvaltning held 25,600 shares of Cytokinetics worth $2.18M as of Q2 2026.
  • KLP Kapitalforvaltning left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #732 holding.
  • KLP Kapitalforvaltning first reported a position in Cytokinetics in Q4 2024 and has held it in 7 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.